Saxenda
Saxenda is now in low supply as Novo Nordisk issues a supply warning till 2023
SG Tylor
Due to a shortage of Novo Nordisk’s popular obesity medicine Wegovy, there has been a surge in demand for their ...
GLP-1 medications from Novo Nordisk are being examined in Europe following reports suggest potential suicide risks
SG Tylor
Following reports of two cases of suicidal thoughts and one case of self-harm among users in Iceland, the European Medicines ...
